#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Acute myeloid leukaemia Neoplasm malignant Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Asthma Dermatitis atopic Breast cancer metastatic Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Adenoid cystic carcinoma Acute graft versus host disease in skin Infertility male Cholangitis sclerosing Multifocal motor neuropathy Small intestine leiomyosarcoma Juvenile chronic myelomonocytic leukaemia Glomerulonephritis membranoproliferative Acquired haemophilia Malformation venous Ornithine transcarbamoylase deficiency Leukodystrophy Necrotising myositis Prostate cancer Hypereosinophilic syndrome More trials…

    Learn about Rare Diseases

    Angiosarcoma – Treatment Brain stem glioma – Trials in Disease Cytokine release syndrome – Treatment Osteosarcoma recurrent – Life with Disease Hereditary neuropathic amyloidosis – Life with Disease Hereditary ataxia – Diagnostics Myelodysplastic syndrome with excess blasts – Life with Disease Uterine leiomyosarcoma – Basic Information Alport’s syndrome – Trials in Disease Chondrosarcoma – Treatment More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Pelareorep Threonine Gliquidone Water For Injection Lidocaine Hydrochloride Ezetimibe Tenofovir Alafenamide Avelumab Gskvx000000017033 Pyruvic Acid VTX-002 Dorzolamide MAPLIRPACEPT SELTOREXANT Esmolol Hydrochloride Adrc Progesterone, Micronised Benzyl Alcohol Cusatuzumab Abrocitinib More therapies…

    Learn about Your Condition

    Liver transplant Propionic acidaemia Sarcoidosis Aortic disorder Laryngeal cancer stage I Anorexia nervosa Vulvovaginal dryness Binge eating Procedural pain Myxoid liposarcoma Acute on chronic liver failure Bronchopulmonary aspergillosis Rasmussen encephalitis Gallbladder cancer Reperfusion injury More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Metabolism

  • Study on the Effects of Metreleptin for Patients with Partial Lipodystrophy

    Recruiting

    3 1 1 1 1
    Investigated Diseases:
    • Partial lipodystrophy
    Investigated Drugs:
    • Metreleptin
    France Germany Italy

  • Study on How Abiraterone Affects Oxycodone in Men with Prostate Cancer

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Prostate cancer
    Investigated Drugs:
    • Oxycodone Hydrochloride
    The Netherlands

  • Comparison of dapagliflozin and oral semaglutide effectiveness in type 2 diabetes patients based on insulin resistance or secretion deficit

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Type 2 diabetes mellitus
    Investigated Drugs:
    • Insulin Glargine
    • Dapagliflozin
    • Semaglutide
    Italy

  • Long-Term Safety and Efficacy of KL1333 in Adults with Primary Mitochondrial Disease

    Recruiting

    2 1 1
    Investigated Drugs:
    • 2-Isopropyl-3H-Naphtho(1,2-D)Imidazole-4,5-Dione
    Belgium Czechia Denmark France Germany Italy +1

  • Effect of Metformin Hydrochloride on Inflammation and Aging Biomarkers in Pre‑diabetic Patients

    Not yet recruiting

    3 1 1 1
    Investigated Diseases:
    • Glucose tolerance impaired
    Investigated Drugs:
    • Metformin Hydrochloride
    Spain

  • Study on Imaging Beta Cells in Patients with a History of Gestational Diabetes Using Exenatide

    Not yet recruiting

    2 1 1 1
    Investigated Diseases:
    • Gestational diabetes
    Investigated Drugs:
    • Exenatide
    The Netherlands
Previous Page
1 2 3 4 … 7
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!